You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 8,691,507


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,691,507 protect, and when does it expire?

Patent 8,691,507 protects TAZVERIK and is included in one NDA.

This patent has sixty-four patent family members in sixteen countries.

Summary for Patent: 8,691,507
Title:Inhibitors of human EZH2 and methods of use thereof
Abstract: The invention relates to determining the presence of an EZH2 gene mutation in a sample from a subject and inhibition of wild-type and certain mutant forms of human histone methyltransferase EZH2, the catalytic subunit of the PRC2 complex which catalyzes the mono-through tri-methylation of lysine 27 on histone H3 (H3-K27). In one embodiment the inhibition is selective for the mutant form of the EZH2, such that trimethylation of H3-K27, which is associated with certain cancers, is inhibited. The methods can be used to treat cancers including follicular lymphoma and diffuse large B-cell lymphoma (DLBCL). Also provided are methods for identifying small molecule selective inhibitors of the mutant forms of EZH2 and also methods for determining responsiveness to an EZH2 inhibitor in a subject.
Inventor(s): Copeland; Robert A. (Lexington, MA), Richon; Victoria M. (Wellesley, MA), Scott; Margaret D. (Beverly, MA), Sneeringer; Christopher J. (San Francisco, CA), Kuntz; Kevin W. (Woburn, MA), Knutson; Sarah K. (Cambridge, MA), Pollock; Roy M. (Medford, MA)
Assignee: Epizyme, Inc. (Cambridge, MA)
Application Number:13/949,026
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,691,507

Introduction

United States Patent 8,691,507, granted to Epizyme, is a significant patent in the field of cancer diagnosis and treatment, particularly focusing on the identification and treatment of cancers associated with EZH2 mutations. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Patent Title and Number:

  • Title: Methods for diagnosing and treating cancers associated with EZH2 mutations
  • Number: 8,691,507

Assignee:

  • Epizyme, Inc.

Background: The patent addresses the identification of patients carrying EZH2 oncogenic mutations and their treatment with EZH2 inhibitors. EZH2 (Enhancer of Zeste Homolog 2) is a protein that plays a crucial role in gene regulation, and mutations in the EZH2 gene have been associated with various types of cancer, including lymphomas and leukemias[5].

Scope of the Patent

The scope of the patent is defined by its claims, which outline the specific aspects of the invention that are protected.

Independent Claims

Independent claims are the broadest claims in a patent and define the core of the invention. For Patent 8,691,507, these claims typically include:

  • Method Claims: These cover the processes for identifying patients with EZH2 mutations and administering EZH2 inhibitors as a treatment.
  • Composition Claims: These may include the specific formulations of EZH2 inhibitors and any diagnostic kits or tools used in the identification process.

Dependent Claims

Dependent claims are narrower and build upon the independent claims. They often specify particular embodiments or variations of the invention, such as:

  • Specific Mutations: Claims might specify particular EZH2 mutations that are targeted.
  • Treatment Regimens: These could include different dosages, administration routes, or combination therapies involving EZH2 inhibitors.

Claim Analysis

Claim Length and Count

Research has shown that the length and count of independent claims can be indicative of patent scope. Narrower claims, as measured by claim length and count, are often associated with a higher probability of grant and a shorter examination process[3].

For Patent 8,691,507, the claims would need to be analyzed to determine their breadth and specificity. Generally, patents with narrower claims tend to have a clearer and more defined scope, which can reduce the risk of litigation and licensing issues.

Claim Language

The language used in the claims is crucial for defining the scope of protection. Clear and specific language helps in avoiding ambiguity and ensures that the patent covers the intended invention without being overly broad. The claims in this patent would need to carefully define what constitutes an EZH2 mutation, how patients are identified, and the specific treatments covered.

Patent Landscape

Global Patent System

The patent landscape for inventions like this one is global, with various international intellectual property offices playing a role. Tools like the Global Dossier and the Common Citation Document (CCD) help in navigating this landscape by providing access to related applications and prior art citations across different IP offices[1].

Related Patents and Applications

To understand the broader landscape, one would need to search for related patents and applications, both in the U.S. and internationally. Databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO) are essential resources for this purpose[1].

Technological Trends

The patenting trends in the field of biotechnology and pharmaceuticals, particularly in cancer treatment, are significant. The USPTO classifies patents into various technology areas, and data from these classifications can provide insights into the focus and trends in patenting over time. For instance, the increase in electrical engineering and information and communication technologies (ICT) patents has also influenced the biotech sector, with advancements in diagnostic tools and therapeutic approaches[4].

Search and Examination Process

Preliminary Search

Conducting a preliminary patent search is crucial to understand the prior art and ensure the novelty of the invention. Tools like the Patent Public Search and resources from Patent and Trademark Resource Centers (PTRCs) are invaluable for this purpose[1].

Examination Process

The examination process for patents involves evaluating the claims against prior art to ensure they meet the criteria of novelty, non-obviousness, and utility. The Patent Examination Data System (PEDS) provides access to bibliographic data for all publicly available patent applications, which can be useful in understanding how similar patents have been examined and granted[1].

Key Takeaways

  • Specific Claims: The patent's claims are critical in defining its scope and ensuring it is not overly broad.
  • Global Landscape: Understanding the global patent landscape is essential for navigating related applications and prior art.
  • Technological Trends: Keeping abreast of technological trends in biotechnology and pharmaceuticals can provide insights into the competitive environment.
  • Search and Examination: A thorough preliminary search and understanding of the examination process are vital for the patent's validity and enforceability.

FAQs

Q: What is the main focus of United States Patent 8,691,507? A: The main focus of this patent is on methods for diagnosing and treating cancers associated with EZH2 mutations.

Q: How do independent claims affect the scope of a patent? A: Independent claims define the broadest aspects of the invention and are crucial in determining the patent's scope. Narrower independent claims are often associated with a higher probability of grant and a shorter examination process.

Q: What tools can be used to search for related patents and applications globally? A: Tools such as the Global Dossier, Common Citation Document (CCD), and databases from international intellectual property offices like the EPO, JPO, and WIPO are useful for searching related patents and applications globally.

Q: Why is it important to conduct a preliminary patent search? A: Conducting a preliminary patent search helps in understanding the prior art and ensuring the novelty of the invention, which is crucial for the patent's validity.

Q: How does the examination process impact the scope of patent claims? A: The examination process tends to narrow the scope of patent claims, ensuring they meet the criteria of novelty, non-obviousness, and utility. This process can result in shorter and more specific claims[3].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office: https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. NCSES - Invention: U.S. and Comparative Global Trends: https://ncses.nsf.gov/pubs/nsb20204/invention-u-s-and-comparative-global-trends
  5. Bay City Capital - Epizyme Granted Patent Covering Diagnosis and Treatment of Cancers Associated with EZH2 Mutation: http://baycitycapital.com/portfolio-news/epizyme-granted-patent-covering-diagnosis-treatment-cancers-associated-ezh2-mutation-2/

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,691,507

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Epizyme Inc TAZVERIK tazemetostat hydrobromide TABLET;ORAL 211723-001 Jan 23, 2020 RX Yes Yes ⤷  Subscribe ⤷  Subscribe METHOD OF TREATING RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA POSITIVE FOR AN ENHANCER OF ZESTE HOMOLOG 2 (EZH2) MUTATION ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,691,507

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2011298987 ⤷  Subscribe
Australia 2013232229 ⤷  Subscribe
Australia 2017276284 ⤷  Subscribe
Australia 2018201176 ⤷  Subscribe
Australia 2019250181 ⤷  Subscribe
Australia 2020203245 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.